INNOVATION
to heal patients and give them hope
100 REASONS TO
CELEBRATE
The Stem Cell Transplant Program receives accreditation, and
specialists treat their 100th patient
has been a banner year for
the Autologous Transplant
Program at Scott & White
Healthcare. The program achieved
two notable distinctions in 2014: in
February the 100th patient received
a stem cell transplant, and in July
the program received accreditation by
the Foundation for the Accreditation
of Cellular Therapy (FACT), an
internationally recognized body that
sets standards for stem cell therapy.
Scott & White is the only FACTaccredited stem cell transplant program
in Central Texas.
“Our goal from the beginning of
It
10
THE CATALYST December 14 | sw.org
the program in 2005 was to be FACT
accredited, because it means we
provide a level of quality therapy across
the continuum of what patients need,”
says Christian Cable, MD, an
oncologist and director of the
Autologous Transplant Program. “It’s
a significant milestone to achieve the
FACT accreditation and treat our
100th patient in the same year,”
he says.
The accreditation assures stem
cell transplant patients that they will
receive best-in-class treatment at
Scott & White, just as they would at
any other FACT accredited center,
says pathologist Walter J. Linz, MD,
program processing and collection
facility medical director. “This is
important because it allows Central
Texas patients to have the opportunity
to stay home to receive the best care.
They get the same level of care in
Central Texas as they would at any
other FACT accredited program,”
says Dr. Linz, who specializes in
transfusion medicine. Dr. Linz also
believes the integrated resources and
pool of talent available at Scott &
White were important catalysts to
achieving certification.
Autologous blood stem cell